Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Genest

Showing results (81-90 of 214) with videos related to

Pageof 22
Sort By:
The American Journal of Cardiology|November 11, 2008
Comparison of treatment of severe high-density lipoprotein cholesterol deficiency in men with daily atorvastatin (20 mg) versus fenofibrate (200 mg) versus extended-release niacin (2 g)Khalid Alrasadi, Zuhier Awan, Khalid Alwaili, et al.
Journal of Interventional Cardiology|March 20, 2024
Meta-Analysis of Randomized Trials: Efficacy and Safety of Colchicine for Secondary Prevention of Cardiovascular DiseaseElie Akl, Nazanin Sahami, Christopher Labos, et al.
Circulation|February 24, 2010
Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trialsSamia Mora, Robert J Glynn, Judith Hsia, et al.
Human Genetics|February 28, 2003
Compound heterozygosity at the sphingomyelin phosphodiesterase-1 (SMPD1) gene is associated with low HDL cholesterolChing Yin Lee, Larbi Krimbou, Jérôme Vincent, et al.
Journal of Psychosomatic Research|May 19, 2018
Anxiety, depression, and health-related quality of life in heterozygous familial hypercholesterolemia: A systematic review and meta-analysisLeo E Akioyamen, Jacques Genest, Shubham D Shan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 2, 2023
Docetaxel as a Model Compound to Promote HDL (High-Density Lipoprotein) Biogenesis and Reduce AtherosclerosisHong Y Choi, Iulia Iatan, Isabelle Ruel, et al.
Journal of Lipid Research|May 18, 2005
Biogenesis and speciation of nascent apoA-I-containing particles in various cell linesLarbi Krimbou, Houssein Hajj Hassan, Sacha Blain, et al.
Peptides|March 20, 2014
Circulating levels of the vasoactive peptide urotensin II in patients with acute coronary syndrome and stable coronary artery diseaseHamood Al Kindi, Anouar Hafiane, Zhipeng You, et al.
The Canadian Journal of Cardiology|September 16, 2019
The Lifelong Burden of Homozygous Familial HypercholesterolemiaAmbuja Banerjee, Latifah Alothman, Patrick Couture, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 3, 2005
Evidence for a gene influencing high-density lipoprotein cholesterol on chromosome 4q31.21Zari Dastani, Leigh Quiogue, Christopher Plaisier, et al.
Pageof 22

Showing results (81-90 of 214) with videos related to

Sort By:
Pageof 22
The American Journal of Cardiology|November 11, 2008
Comparison of treatment of severe high-density lipoprotein cholesterol deficiency in men with daily atorvastatin (20 mg) versus fenofibrate (200 mg) versus extended-release niacin (2 g)Khalid Alrasadi, Zuhier Awan, Khalid Alwaili, et al.
Journal of Interventional Cardiology|March 20, 2024
Meta-Analysis of Randomized Trials: Efficacy and Safety of Colchicine for Secondary Prevention of Cardiovascular DiseaseElie Akl, Nazanin Sahami, Christopher Labos, et al.
Circulation|February 24, 2010
Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trialsSamia Mora, Robert J Glynn, Judith Hsia, et al.
Human Genetics|February 28, 2003
Compound heterozygosity at the sphingomyelin phosphodiesterase-1 (SMPD1) gene is associated with low HDL cholesterolChing Yin Lee, Larbi Krimbou, Jérôme Vincent, et al.
Journal of Psychosomatic Research|May 19, 2018
Anxiety, depression, and health-related quality of life in heterozygous familial hypercholesterolemia: A systematic review and meta-analysisLeo E Akioyamen, Jacques Genest, Shubham D Shan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 2, 2023
Docetaxel as a Model Compound to Promote HDL (High-Density Lipoprotein) Biogenesis and Reduce AtherosclerosisHong Y Choi, Iulia Iatan, Isabelle Ruel, et al.
Journal of Lipid Research|May 18, 2005
Biogenesis and speciation of nascent apoA-I-containing particles in various cell linesLarbi Krimbou, Houssein Hajj Hassan, Sacha Blain, et al.
Peptides|March 20, 2014
Circulating levels of the vasoactive peptide urotensin II in patients with acute coronary syndrome and stable coronary artery diseaseHamood Al Kindi, Anouar Hafiane, Zhipeng You, et al.
The Canadian Journal of Cardiology|September 16, 2019
The Lifelong Burden of Homozygous Familial HypercholesterolemiaAmbuja Banerjee, Latifah Alothman, Patrick Couture, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 3, 2005
Evidence for a gene influencing high-density lipoprotein cholesterol on chromosome 4q31.21Zari Dastani, Leigh Quiogue, Christopher Plaisier, et al.
Pageof 22